George Zenzerovich1 and Tim Q Duong2
1Radiology, Stony Brook University, Stony Brook, NY, United States, 2Stony Brook University, Stony Brook, NY, United States
Synopsis
Texture features obtained from peritumoral area of diagnostic MR image of Glioblastoma Multiforme were used to improve texture based prediction of tumor progression. The peritumoral area was drawn and examined then derived texture features were added to conventional model to improve performance.
Introduction
The most aggressive malignant brain tumor, Glioblastoma
Multiform, carries almost inevitable recurrence. [1] MR derived features of glioblastoma
have previously shown an ability to predict patient survival and progression. [2]
The goal of this study was to investigate whether MRI-based texture features
derived from the peritumoral area can improve the prediction of tumor
progression when added to current MR based texture models in newly diagnosed Glioblastoma
Multiforme patients. This study defines the peritumoral area as five millimeters
from the enhancing edge of the tumor. This
area is often not removed during primary tumor resection and has been shown to contain
cancer cells. [3] Under a T1 weighted MR image these cells should enhance and
alter their appearance on a T1 scan which will be picked up via texture
analysis. Methods
Patient data were obtained
from the TCGA-GBM dataset from the National Cancer Institute.[5] The MR images
were obtained through the Cancer Imaging Achieve. Both are HIPAA compliant
public access datasets. Progression was defined by the TCGA-GBM dataset as new tumor event. Each patient had
a histology confirmed Glioblastoma Multiforme diagnosis. This study used the
provided segmentations from Spyridon et al.[6] to identify the enhancing tumor,
non-enhancing tumor, and edema regions of each patient. The peritumoral area
was generated by merging the enhancing tumor and non-enhancing tumor regions, then
generating a five-millimeter ring around the merged region. (Figure 1) Texture
features from each region were extracted using LIFEx v5.10 texture protocol. A
total of 168 features were extracted per scan including histogram, shape, and
first order features. Least absolute shrinkage
and selection operator (LASSO) was used to determine the most relevant features.
Relevant features were then used to create a logistic regression prediction 7-month
progression in patients. Models were evaluated using receiver operating
characteristic curve and Kaplan Meier analysis. All statistics conducted in R
version 3.6.1. Results
The LASSO selected features represented all regions of the
tumor. The set containing radiomic features that included the peritumoral area
produced an area under curve (AUC) of 0.83 while the set without peritumoral
features returned an AUC of 0.73. (Figure 2) A larger AUC indicates a more
accurate predictor where an AUC of 0.5 would be equivalent to random selection.
The Kaplan-Meier analysis showed that there is a significant difference between
the greater than seven month progression and the less than seven month prediction
groups. Discussion
Radiomic prediction is a valuable tool in the clinical
setting as it can provide information about patient outcomes form the onset. The
peritumoral region needs to be considered when evaluating glioblastoma multiforme
tumors as cancer cells are almost always present outside of the tumor [4]. These
cells will not be removed during resection and therefore offer predictive power
towards progression. The inclusion of this region in this study showed an
increase in AUC from 0.76 to 0.83. This may be further improved by examining
the peritumoral area in different MR modalities such as T2 or Flair. Conclusion
Radiomic features can be extracted from the peritumoral area
of glioblastoma multiforme tumors. These features have the ability aid the prediction
of time to progression from these images when combined with features from other
tumor regions. Predictions made form data that included the peritumoral area of
the tumor were more accurate than predictions made from data that did not
include this region. Acknowledgements
No acknowledgement found.References
1. C.B.T.R.
of the United States, et al., Cbtrus statistical report: primary brain and
central
nervous system tumors diagnosed in the United States, 2004–2006, february
2010,
Hinsdale, IL: central Brain Tumor Registry of the United States, http://www.
cbtrus.org/2010
2. Jain, R. et al. Outcome prediction in patients
with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on
the nonenhancing component of the tumor. Radiology 272, 484–493 (2014).
3. Kim, Jung Youn, et al. "Radiomics in
peritumoral non-enhancing regions: fractional anisotropy and cerebral blood
volume improve prediction of local progression and overall survival in patients
with glioblastoma." Neuroradiology (2019): 1-12.
4. Silbergeld, Daniel L., and Michael R. Chicoine.
"Isolation and characterization of human malignant glioma cells from
histologically normal brain." Journal of neurosurgery 86.3 (1997): 525-531.
5. Scarpace, L., Mikkelsen, T., Cha, soonmee, Rao, S., Tekchandani, S., Gutman, D., … Pierce, L. J. (2016). Radiology Data from The Cancer Genome Atlas Glioblastoma Multiforme [TCGA-GBM] collection. The Cancer Imaging Archive. http://doi.org/10.7937/K9/TCIA.2016.RNYFUYE9
6. Spyridon Bakas, Hamed Akbari, Aristeidis Sotiras, Michel Bilello, Martin Rozycki, Justin Kirby, John Freymann, Keyvan Farahani, and Christos Davatzikos. (2017) Segmentation Labels and Radiomic Features for the Pre-operative Scans of the TCGA-GBM collection. The Cancer Imaging Archive. https://doi.org/10.7937/K9/TCIA.2017.KLXWJJ1Q